AI replacing office workers could be as boon to Bitcoin, analysts say. Illustration: Andrés Tapia; Source: Shutterstock.AI replacing office workers could be as boon to Bitcoin, analysts say. Illustration: Andrés Tapia; Source: Shutterstock.

Citrini AI report terrified Wall Street. Here’s why its vision is a boon for Bitcoin’s price

2026/02/25 01:07
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

First, Alap Shah said artificial intelligence will nuke the world economy.

Then, the report he co-authored with Citrini Research further inflated AI bubble fears and triggered a mass selloff of everything from delivery to payment stocks — an event that dragged cryptocurrency prices down with it.

Now, the Lotus Technology Management chief investment officer says he is surprised by how visceral the reaction to the paper’s vision of the future was.

“I thought there was going to be a small reaction, “ Shah told Bloomberg after his screed went viral over the weekend. “It was definitely larger than we expected.”

The report outlines a potential future based on one core thesis: that AI will only get smarter, replace troves of white-collar workers, and decimate consumer spending, laying waste to a slew of industries and even countries’ economies.

Industries like insurance, banking and food delivery are just some sectors that would be affected by the onslaught, Shah and Citrini Research, the independent research firm, wrote.

The report came at a troubling time for the crypto industry.

The general tech selloff pulled Bitcoin’s price below $63,000 for the first time since October, deepening a major market pullback that has shaved over $2 trillion off the digital asset’s market cap, roughly half of its record high in October.

Yet, crypto market watchers are bullish.

The dark future outlined in the Citrini report could even benefit the crypto industry, experts, including Maelstrom’s CIO Arthur Hayes, say.

Pump Bitcoin

The Citrini report only mentions crypto in passing. It notes that AI agents, programmes powered by large language models, will automate commerce.

When they do, they’ll likely choose to use stablecoins rather than traditional payment rails, due to their near-instant settlements and transaction cost “measured in fractions of a penny.”

This will likely, Citrini and Shah write, lead to a decline in payment companies’ stock prices.

Yet the mass layoffs and economic slump envisioned in the report could pump the price of Bitcoin and other cryptocurrencies.

Laurens Fraussen, research analyst at Kaiko, says this is essentially what happened when the US Federal Reserve stepped in after the pandemic.

“When the economy is in the gutter, the Fed often ramps up money printing,” Fraussen told DL News.

“Bitcoin goes up in response to the increased money supply and concerns about currency debasement,” he said.

Hayes, the co-founder of BitMEX, made a similar prediction earlier in February, saying that the US central bank will have to plough liquidity into the economy to avoid a repeat of the 2008 financial crisis.

“Deflation is bad, but ultimately good for fiat credit-sensitive assets like Bitcoin,” Hayes wrote in a February 17 blog.

Eric Johansson is DL News’ managing editor. Got a tip? Email him at eric@dlnews.com.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09